108 related articles for article (PubMed ID: 5880480)
1. [On the problem of a cancerogenic effect of orally administered estrogen-gestagenic-hormonal combinations. A clinical contribution].
Froewis J; Kremer H
Wien Klin Wochenschr; 1965 Oct; 77(42):792-8. PubMed ID: 5880480
[No Abstract] [Full Text] [Related]
2. Effect of selected estrogens and progestins on human chromosomes in vitro.
Stenchever MA; Jarvis JA; Kreger NK
Obstet Gynecol; 1969 Aug; 34(2):249-51. PubMed ID: 4183817
[No Abstract] [Full Text] [Related]
3. Wayward sisters. Progestin siblings exert opposite effects on monkey hearts.
Beckman M
Sci Aging Knowledge Environ; 2004 Oct; 2004(41):nf91. PubMed ID: 15483332
[No Abstract] [Full Text] [Related]
4. [Genital hemorrhage in early pregnancy].
Staemmler HJ
Dtsch Med Wochenschr; 1973 Sep; 98(36):1683. PubMed ID: 4741245
[No Abstract] [Full Text] [Related]
5. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives.
Med Lett Drugs Ther; 1968 Aug; 10(17):66-8. PubMed ID: 5730144
[No Abstract] [Full Text] [Related]
7. [Electroencephalographic findings in patients treated by synthetic estroprogestinic preparations].
Ferroni A; Marinelli M; Lauro V; Bergonzi P
Arch Ostet Ginecol; 1969; 74(3):236-50. PubMed ID: 5402697
[No Abstract] [Full Text] [Related]
8. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Edelman AB; Koontz SL; Nichols MD; Jensen JT
Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
[TBL] [Abstract][Full Text] [Related]
9. [The effect of two contraceptive methods (EP vs. IUD) in relation to inflammatory changes and CIN].
Cipolla L; Manzi P; Giannetta G; Ferrante B; Zagni R
Minerva Ginecol; 1993 Jun; 45(6):315-20. PubMed ID: 8355888
[TBL] [Abstract][Full Text] [Related]
10. [Vascular sclerosis in ovaries after gestagen-estrogen medication].
Aumüller G; Watzka M
Med Welt; 1970 Oct; 40():1735-9. PubMed ID: 5478124
[TBL] [Abstract][Full Text] [Related]
11. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices.
Ober WB
Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919
[No Abstract] [Full Text] [Related]
12. [Study of hepatic function during hormonal anti-ovulatory treatment].
Bayot D
Bull Soc R Belge Gynecol Obstet; 1966; 36(6):507-16. PubMed ID: 5990177
[No Abstract] [Full Text] [Related]
13. [1 case of cervical pregnancy under anovulatory therapy].
Ritter J; Dehalleux JM; Muller G; Philippe E; Gandar R
Rev Fr Gynecol Obstet; 1969; 64(1):35-9. PubMed ID: 5391369
[No Abstract] [Full Text] [Related]
14. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
Serup J; Bostofte E; Larsen S; Westergaard J
Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
[TBL] [Abstract][Full Text] [Related]
15. [Hyperplasia of the interstitial tissue of the embryonal testis after ingestion of hormonal products by the mother].
Lewin D; Isidor P
Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):414-5. PubMed ID: 5761248
[No Abstract] [Full Text] [Related]
16. [Hormonal contraceptives in female rowers].
Lisý Z
Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
[No Abstract] [Full Text] [Related]
17. [Incidence of vaginal candidiasis following the use of the oral contraceptive compound of progestogen-estrogen (anovlar)].
Grin EI; Karlovac K; Softić A
Med Glas; 1967 Dec; 21(12):368-70. PubMed ID: 5597783
[No Abstract] [Full Text] [Related]
18. [Exogenous estrogens and carcinoma of the endometrium: a critical analysis of the literature].
Franceschi S; La Vecchia C
Ann Ostet Ginecol Med Perinat; 1980; 101(6):397-403. PubMed ID: 7008676
[No Abstract] [Full Text] [Related]
19. Mucha-Habermann disease following estrogen-progesterone therapy.
Hollander A; Grots IA
Arch Dermatol; 1973 Mar; 107(3):465. PubMed ID: 4692137
[No Abstract] [Full Text] [Related]
20. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
